Liver News and Research

RSS

Bariatric surgery can reduce the risk of obesity-related cancers, study shows

Bariatric surgery can significantly reduce the risk of cancer--and especially obesity-related cancers--by as much as half in certain individuals, according to a study by researchers at Rutgers Robert Wood Johnson Medical School's Center for Liver Diseases and Liver Masses.

26 Mar 2021

UArizona researcher finds a unique approach to tackle both Alzheimer’s disease and diabetes

A University of Arizona Health Sciences researcher examined the role of cholesterol in both Alzheimer's disease and Type 2 diabetes to identify a small molecule that may help regulate cholesterol levels in the brain, making it a potential new therapeutic target for Alzheimer's disease.

25 Mar 2021

Study may provide an explanation for dawn phenomenon in patients with type 2 diabetes

Researchers at Baylor College of Medicine, Shandong University in China and other institutions may have found an explanation for dawn phenomenon, an abnormal increase of blood sugar only in the morning, observed in many patients with type 2 diabetes.

25 Mar 2021

New machine learning algorithm ranks drugs based on efficacy in reducing cancer cell growth

Researchers from the Queen Mary University of London have developed a machine learning algorithm that ranks drugs based on their efficacy in reducing cancer cell growth.

25 Mar 2021

Biomaterials can help modulate the immune activity of liver cells

Biomaterials are substances, natural or manmade, that are used in medicine to interact with the human body for various purposes, such as wound healing and tissue regeneration.

25 Mar 2021

Near-infrared hyperspectral imaging technique can facilitate the diagnosis of fatty liver diseases

Excessive fat accumulation in the liver can lead to serious medical problems, including liver failure. Thus, understanding the distribution of lipids within the liver is a critical step in diagnosing fatty liver diseases.

25 Mar 2021

Fluoxetine (Prozac) performs strongly in vitro against SARS-CoV-2 (including mutants)

Researchers from Finland, to expand on these studies, tested some of these drugs against the new SARS-CoV-2 variants. The study is published on the preprint server bioRxiv.

24 Mar 2021

Repurposed heart and flu drugs that protect platelets improve survival of septic mice

Despite continued improvements in antibiotics and hospital intensive care, staph sepsis - a bloodstream infection caused by Staphylococcus aureus bacteria - still causes severe illness or death in 20 to 30 percent of patients who contract it.

24 Mar 2021

Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis (NASH), often called 'fatty liver hepatitis', can lead to serious liver damage and liver cancer.

24 Mar 2021

New technique traces genetic and epigenetic origins of DNA to reveal hidden cancers

A new technique that can trace which tissues and organs the DNA in our blood comes from has been reported today in the open-access eLife journal.

24 Mar 2021

Study reveals new approach for treating diabetic foot ulcers

A discovery involving multiple teams from across Scripps Research has revealed a powerful new approach for treating diabetic foot ulcers, which affect millions of people in the US and often lead to serious complications.

23 Mar 2021

Nutritional supplement may reduce risk of fatal strokes in patients with rare genetic disorder

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered that a widely used nutritional supplement may significantly reduce the risk of fatal strokes caused by a rare genetic disorder.

23 Mar 2021

Dandelion extract inhibits SARS-CoV-2 in vitro

An exciting new study describes a specific inhibitor of the SARS-CoV-2 found in an extract of the common dandelion that could provide a new and fruitful avenue of drug research.

23 Mar 2021

Study identifies metabolic processes associated with multiple, unrelated diseases

Many older, but also increasingly younger, people suffer from several diseases at the same time. Scientists at the Berlin Institute of Health at Charité – Universitätsmedizin Berlin, together with colleagues from Munich and the United Kingdom, have now identified common risk factors that predispose to multiple even seemingly unrelated diseases.

22 Mar 2021

Most cancer patients with COVID-19 produce antibodies at a rate comparable to general population

Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest of the population--but their ability to do so depends on their type of cancer and the treatments they've received, according to a new study by researchers at Montefiore Health System and Albert Einstein College of Medicine.

22 Mar 2021

SARS-CoV-2 infection is circadian

An international team of researchers has found that angiotensin-converting enzyme 2 (ACE2) levels in lung cells vary over the day, affecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The virus entry and replication in the lung cells also have a rhythmic cycle, suggesting circadian processes can affect the virus's life cycle.

22 Mar 2021

Liver News and Research

Bariatric surgery can reduce the risk of obesity-related cancers, study shows

UArizona researcher finds a unique approach to tackle both Alzheimer’s disease and diabetes

Study may provide an explanation for dawn phenomenon in patients with type 2 diabetes

New machine learning algorithm ranks drugs based on efficacy in reducing cancer cell growth

Biomaterials can help modulate the immune activity of liver cells

Near-infrared hyperspectral imaging technique can facilitate the diagnosis of fatty liver diseases

Fluoxetine (Prozac) performs strongly in vitro against SARS-CoV-2 (including mutants)

Repurposed heart and flu drugs that protect platelets improve survival of septic mice

Auto-aggressive immune cells cause liver immune pathology in non-alcoholic steatohepatitis

New technique traces genetic and epigenetic origins of DNA to reveal hidden cancers

Study reveals new approach for treating diabetic foot ulcers

Nutritional supplement may reduce risk of fatal strokes in patients with rare genetic disorder

Dandelion extract inhibits SARS-CoV-2 in vitro

Study identifies metabolic processes associated with multiple, unrelated diseases

Most cancer patients with COVID-19 produce antibodies at a rate comparable to general population

SARS-CoV-2 infection is circadian

Disease-driving B cells play a role in the development of NAFLD

$11 million COBRE funding will help create Center for Pre-Clinical Cancer Research at LSU SVM

Underrepresentation in genomic databases may affect therapy selection for minority patients

New technique uses cell's own recycling machinery to destroy disease-causing proteins

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News